Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plasma Renin Activity–Guided Strategy for the Management of Hypertension
Nicole Olson, Beth DeJongh, Augustus Hough, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2012) Vol. 32, Iss. 5, pp. 446-455
Closed Access | Times Cited: 21

Showing 21 citing articles:

Pharmacogenetics and Cardiovascular Disease—Implications for Personalized Medicine
Julie A. Johnson, Larisa H. Cavallari
Pharmacological Reviews (2013) Vol. 65, Iss. 3, pp. 987-1009
Open Access | Times Cited: 128
Angiotensin-(1-7) modulates renin–angiotensin system associated with reducing oxidative stress and attenuating neuronal apoptosis in the brain of hypertensive rats
Teng Jiang, Li Gao, Jian‐Quan Shi, et al.
Pharmacological Research (2012) Vol. 67, Iss. 1, pp. 84-93
Closed Access | Times Cited: 80
Assessment and management of resistant hypertension
Raj Padwal, Simon W. Rabkin, Nadia Khan
Canadian Medical Association Journal (2014) Vol. 186, Iss. 18, pp. E689-E697
Open Access | Times Cited: 14
Epidemiology, Prognosis, and Treatment of Resistant Hypertension
Steven M. Smith
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2013) Vol. 33, Iss. 10, pp. 1071-1086
Closed Access | Times Cited: 14
CYP2C19 genetic variation and individualized clopidogrel prescription in a cardiology clinic
Seyed Abbas Mirabbasi, Koroush Khalighi, Yin Wu, et al.
Journal of Community Hospital Internal Medicine Perspectives (2017) Vol. 7, Iss. 3, pp. 151-156
Open Access | Times Cited: 14
The spectrum of plasma renin activity and hypertension diseases: Utility, outlook, and suggestions
Zhenni Liu, Lizi Jin, Weiyan Zhou, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 11
Open Access | Times Cited: 8
Treatment of Hypertensive Patients With Diabetes and Microalbuminuria With Combination Indapamide SR/Amlodipine: Retrospective Analysis of NESTOR
Olivier Hanon, Clémence Boully, Laure Caillard, et al.
American Journal of Hypertension (2015) Vol. 28, Iss. 8, pp. 1064-1071
Open Access | Times Cited: 8
Thiazide-Like/Calcium Channel Blocker Agents: A Major Combination for Hypertension Management
Michel E. Safar, Jacques Blacher
American Journal of Cardiovascular Drugs (2014) Vol. 14, Iss. 6, pp. 423-432
Closed Access | Times Cited: 5
Hypertension Treatment at the Crossroads: A Role for Economics?
Peter S. Arno, Deborah Viola
American Journal of Hypertension (2013) Vol. 26, Iss. 11, pp. 1257-1259
Open Access | Times Cited: 5
Plasma Renin Activity Testing to Guide Triple Antirenin System Drug Therapy in a Patient With Difficult-to-Treat Hypertension
Sachil Shah, Christina Coakley, Augustus Hough, et al.
Annals of Pharmacotherapy (2013) Vol. 47, Iss. 11, pp. 1562-1568
Closed Access | Times Cited: 4
Customisation and validation of a low-volume plasma renin activity immunoassay: Enabling of regulatory compliant determination in paediatric trials
Fabian Konstantin Suessenbach, Jutta Tins, Bjoern B. Burckhardt
Practical Laboratory Medicine (2019) Vol. 17, pp. e00144-e00144
Open Access | Times Cited: 4
Renin–Angiotensin System
Michael Gralinski, Liomar A. A. Neves, Olga Tiniakova
Springer eBooks (2015), pp. 665-707
Closed Access | Times Cited: 3
Plasma Renin Activity Testing to Guide Triple Antirenin System Drug Therapy in a Patient With Difficult-to-Treat Hypertension
Sachil Shah, Christina Coakley, Augustus Hough, et al.
Annals of Pharmacotherapy (2013) Vol. 48, Iss. 2, pp. 279-285
Closed Access | Times Cited: 2
Etiological Diagnosis and Personalized Therapy for Hypertension: A Hypothesis of the REASOH Classification
Chong Xu, Moran Li, Weilun Meng, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 2, pp. 261-261
Open Access | Times Cited: 1
Current Therapeutic Approaches to Cardio-Protection in Hypertension
David Parra, Augustus Hough
Current Hypertension Reports (2014) Vol. 16, Iss. 8
Closed Access | Times Cited: 1
Pressor Response to Initial Blood Pressure Monotherapy Is Associated With Cardiovascular Mortality
M. C. Gonzalez, Hillel W. Cohen, M. H. Alderman
American Journal of Hypertension (2014) Vol. 28, Iss. 2, pp. 232-238
Open Access | Times Cited: 1
Laboratory Evaluation of Renal Disease in Childhood
Damien Noone, Valérie S. Langlois
Springer eBooks (2016), pp. 77-105
Closed Access | Times Cited: 1
Renin–Angiotensin System
Michael Gralinski, Liomar A. A. Neves, Olga Tiniakova
Springer eBooks (2015), pp. 1-51
Closed Access | Times Cited: 1
Combination Antihypertensive Treatment With Aliskiren and Blockers of the Renin-Angiotensin System—Reassurance but With a Note of Caution
Rhian M. Touyz
Canadian Journal of Cardiology (2013) Vol. 29, Iss. 5, pp. 521-523
Open Access | Times Cited: 1
Efficacy of a new single-pill combination of a thiazide-like diuretic and a calcium channel blocker (indapamide sustained release/amlodipine) in essential hypertension
Anna F. Dominiczak, M. de Champvallins, Romualda Brzozowska-Villatte, et al.
Journal of Hypertension (2019) Vol. 37, Iss. 11, pp. 2280-2289
Open Access | Times Cited: 1
Laboratory Evaluation of Renal Disease in Childhood
Damien Noone, Valérie S. Langlois
Springer eBooks (2023), pp. 37-68
Closed Access
Page 1

Scroll to top